Dr. Balaji Kalyanaraman, MD, PhD

Dr. Kalyanaraman practices at Virtual Health Center - Dolwick in Erlanger, Kentucky.

Dr. Kalyanaraman's NPI, 1053573659, was assigned on June 26, 2008. Dr. Kalyanaraman holds Kentucky license 51926.

Dr. Kalyanaraman's primary practice is Virtual Health Center - Dolwick, at 1360 Dolwick Drive, Erlanger, KY 41018. The practice phone is (859) 344-5555.

Dr. Kalyanaraman's primary practice is Virtual Health Center - Dolwick in Erlanger, Kentucky. Dr. Kalyanaraman is also affiliated with St. Elizabeth Healthcare Edgewood Hospital. The medical group on file is St. Elizabeth Physicians. Dmand AI also links Dr. Kalyanaraman to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Kalyanaraman's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalyanaraman practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kalyanaraman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Kalyanaraman's licenses on file in 2 states: Kentucky and Wisconsin.

CMS data shows 589 Medicare services from Dr. Kalyanaraman across 8 procedure codes in 2024, for 286 Medicare patients. Medicare paid $48,739 for them.

CMS counts 286 Medicare patients who saw Dr. Kalyanaraman in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalyanaraman's median patient age at 69, with 26% women.

In 2024, Dr. Kalyanaraman wrote 745 Medicare Part D claims for 332 patients. 89% of them were for generic drugs. CMS names the drug for 674 of them, across 9 drugs with 11 or more claims each, at $62,896 in total drug cost. In 2023, CMS named 559 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kalyanaraman for performance year 2024, reported through an alternative payment model (APM). Dr. Kalyanaraman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of prostate resection by Dr. Kalyanaraman, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Kalyanaraman in 2012. 2012 was the busiest year, with 3. Dr. Kalyanaraman's most frequent co-authors are Ayman Mahdy, Michael Anthony Pugnale, MD and Sadhna M. Verma, MD.

CMS Open Payments shows 167 general payments to Dr. Kalyanaraman from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $1,621.